Table 5.
Baseline comparison by race in resveratrol treated subjects (n=14)
| Clinical Measurement | Caucasians (n=5) | Non-Caucasians (n=9) | p | ||
|---|---|---|---|---|---|
| Mean±SD | CI 95% | Mean±SD | CI 95% | ||
| FBG (mg/dl) | 95±10 | 83.0–107 | 102±16 | 90–114 | 0.366 |
| HDL (mg/dl) | 37±3 | 33–40 | 41±6 | 37–46 | 0.136 |
| TG (mg/dl) | 177±100 | 52–301 | 101±38 | 72–130 | 0.170 |
| SBP (mmHg) | 117±5 | 110–123 | 119±6 | 114–124 | 0.415 |
| DBP (mmHg) | 78±3 | 74–82 | 80±2 | 78–81 | 0.233 |
| Waist circ (cm) | 121±12 | 108–135 | 115±10 | 107–122 | 0.258 |
| BMI (kg/m2) | 34.1±2.8 | 30.6–37.6 | 35.6±2.9 | 33.3–37.8 | 0.375 |
| Age (years) | 49±9 | 38–59 | 47±9 | 41–54 | 0.785 |
Comparison of the baseline characteristics and laboratory data of the caucasian and noncaucasian resveratrol treated subjects. FBG: Fasting blood glucose, HDL: High density lipids,
TG: Triglycerides, SBP: Systolic blood pressure, DBP: Diastolic blood pressure, SD: Standard deviation, CI: Confidence interval, BMI: Body mass index.